Hereditary Angioedema News and Research

RSS
Providing personalized care for bleeding disorders

Providing personalized care for bleeding disorders

COVID-19 patients with hypoxia respond positively to a treatment, study shows

COVID-19 patients with hypoxia respond positively to a treatment, study shows

Computational analyses suggest new pathway for inflammatory response to SARS-CoV-2

Computational analyses suggest new pathway for inflammatory response to SARS-CoV-2

C-Path's Transplant Therapeutics Consortium receives positive FDA response for its Letter of Intent

C-Path's Transplant Therapeutics Consortium receives positive FDA response for its Letter of Intent

CSL Behring and Seattle Children's partner to develop gene therapies for primary immunodeficiency diseases

CSL Behring and Seattle Children's partner to develop gene therapies for primary immunodeficiency diseases

Radboudumc researchers find essential mechanism in the disease process of COVID-19

Radboudumc researchers find essential mechanism in the disease process of COVID-19

New, previously unknown form of familial cold urticaria discovered

New, previously unknown form of familial cold urticaria discovered

Treatments for rare diseases affecting children are increasing, study suggests

Treatments for rare diseases affecting children are increasing, study suggests

Study provides new understanding of mysterious 'hereditary swelling'

Study provides new understanding of mysterious 'hereditary swelling'

New antibody can reduce swelling attacks in patients with hereditary angioedema

New antibody can reduce swelling attacks in patients with hereditary angioedema

New drug offers hope to prevent attacks of hereditary angioedema

New drug offers hope to prevent attacks of hereditary angioedema

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Joslin scientists suggest new approach to improve stroke therapy

Joslin scientists suggest new approach to improve stroke therapy

New RNA aptamer can prevent pathogenic protein misfolding

New RNA aptamer can prevent pathogenic protein misfolding

FDA grants 12-year exclusivity to RUCONEST (C1 esterase inhibitor [recombinant])

FDA grants 12-year exclusivity to RUCONEST (C1 esterase inhibitor [recombinant])

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

KalVista raises $33 million in Series B financing to support development of plasma kallikrein inhibitors

Isis Pharmaceuticals announces positive results from Phase 1 study of ISIS-PKK Rx for HAE treatment

Isis Pharmaceuticals announces positive results from Phase 1 study of ISIS-PKK Rx for HAE treatment

UC San Diego Health System opens nation's first angioedema treatment center

UC San Diego Health System opens nation's first angioedema treatment center

FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

Fabry disease awareness: an interview with Dr. Hartmann Wellhoefer, Head of Medical Affairs, Rare Disease, Shire

Fabry disease awareness: an interview with Dr. Hartmann Wellhoefer, Head of Medical Affairs, Rare Disease, Shire